Drug intelligence / Profile preview

crotonoside

Development stage
Preclinical
Lead developer
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Intraperitoneal, Intravenous, Oral
01

Overview

Crotonoside is a naturally occurring nucleoside analogue, specifically an isoguanosine derivative, originally isolated from the seeds of *Croton tiglium* L. It is currently being investigated for its potential as an anti-leukemic agent, particularly in acute myeloid leukemia (AML). Crotonoside exerts its effects through multiple mechanisms, including the inhibition of FLT3 activation, reduction of HDAC3 and HDAC6 expression, and downregulation of APOBEC3G. It also disrupts DNA synthesis and causes mitochondrial dysfunction by inhibiting mitochondrial DNA polymerase γ, leading to the accumulation of reactive oxygen species (ROS) and the induction of ferroptosis via the p62/KEAP1 autophagy pathway. Historically, crotonoside has been recognized as a bioactive component in traditional medicine for treating conditions such as constipation, inflammation, and rheumatism.

Other names
isoguanosine2-hydroxyadenosine
02

Targets

APOBEC3GPOLG (Mitochondrial DNA polymerase gamma)FLT3 (Fms related receptor tyrosine kinase 3)HDAC3 (Histone Deacetylase 3)HDAC6 (Histone deacetylase 6)DNA

Beyond the preview

Go deeper on crotonoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on crotonoside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call